BYVASDA Trademark

Trademark Overview


On Wednesday, September 23, 2020, a trademark application was filed for BYVASDA with the United States Patent and Trademark Office. The USPTO has given the BYVASDA trademark a serial number of 79298748. The federal status of this trademark filing is REGISTERED as of Tuesday, August 17, 2021. This trademark is owned by Innovent Biologics (Suzhou) Co., Ltd.. The BYVASDA trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for the treatment of cancer for human purposes; biochemical medicines for the treatment of cancer; liquid medicines for the treatment of cancer; blood products, namely, blood plasma, blood for medical purposes; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer for medical purposes; biological tissue cultures for medical purposes; drugs for the treatment of cancer for medical purposes; diagnostic preparations for medical purposes; vaccines; injectable pharmaceuticals for treatment of anaphylactic reactions
byvasda

General Information


Serial Number79298748
Word MarkBYVASDA
Filing DateWednesday, September 23, 2020
Status700 - REGISTERED
Status DateTuesday, August 17, 2021
Registration Number6451033
Registration DateTuesday, August 17, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements


Description of MarkThe mark consists of stylized letters "BYVASDA" and a dandelion on its left side.
Goods and ServicesMedicines for the treatment of cancer for human purposes; biochemical medicines for the treatment of cancer; liquid medicines for the treatment of cancer; blood products, namely, blood plasma, blood for medical purposes; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer for medical purposes; biological tissue cultures for medical purposes; drugs for the treatment of cancer for medical purposes; diagnostic preparations for medical purposes; vaccines; injectable pharmaceuticals for treatment of anaphylactic reactions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameInnovent Biologics (Suzhou) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Monday, February 14, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, January 25, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, January 25, 2022FINAL DISPOSITION PROCESSED
Wednesday, November 17, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 17, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 21, 2021REFUSAL PROCESSED BY IB
Wednesday, February 3, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 3, 2021REFUSAL PROCESSED BY MPU
Saturday, January 16, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 15, 2021NON-FINAL ACTION WRITTEN
Tuesday, January 12, 2021ASSIGNED TO EXAMINER
Friday, December 4, 2020APPLICATION FILING RECEIPT MAILED
Monday, November 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 26, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB